加载中
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
前收盘价
US$45.36
+US$0.94 · +2.12%
盘后
US$45.36
US$0.00 · 0.00%
10月12日 16:39 ET
盘中时间采用ET。市场数据可能有所延迟。
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
日内区间
当前US$45.36
52周区间
当前US$45.36
盘中时间采用ET。市场数据可能有所延迟。
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
日内区间
当前US$45.36
52周区间
当前US$45.36
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 13.74亿 USD | 13.07亿 USD | 12.45亿 USD | 10.45亿 USD | 10.11亿 USD |
| 销货成本 | 6.49亿 USD | 5.74亿 USD | 5.68亿 USD | 4.74亿 USD | 4.43亿 USD |
| 毛利 | 7.25亿 USD | 7.33亿 USD | 6.76亿 USD | 5.71亿 USD | 5.68亿 USD |
| 研究与开发 | 5588.4万 USD | 5442.6万 USD | 5260.2万 USD | 4715.2万 USD | 4356.5万 USD |
| 销售、一般及管理费用 | 5.28亿 USD | 4.78亿 USD | 5.03亿 USD | 4.54亿 USD | 4.15亿 USD |
| 营业费用 | 5.84亿 USD | 5.33亿 USD | 5.56亿 USD | 5.01亿 USD | 4.58亿 USD |
| 利息支出 | 3108.7万 USD | 3729.7万 USD | 3977.5万 USD | 2890.5万 USD | 3548.5万 USD |
| 折旧和摊销 | 7428.1万 USD | 5130.5万 USD | 5140万 USD | 6951.9万 USD | 7074.3万 USD |
| 营业利润 | 1.41亿 USD | 2亿 USD | 1.21亿 USD | 7005.4万 USD | 1.1亿 USD |
| 净利润 | 4705.5万 USD | 1.32亿 USD | 6445.9万 USD | −8058.2万 USD | 6254.2万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$37.50
下跌空间 17.33%年度分割调整后的每股现金分配。
US$0.80
2024年（完整年度）0.0% 自从 2020
US$0.80
2,020
US$0.80
2,021
US$0.80
2,022
US$0.80
2,023
US$0.80
2,024
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2025年9月15日 | US$0.20Quarterly | 2025年9月15日 | 2025年10月3日 |
股息 | 2025年6月13日 | US$0.20Quarterly | 2025年6月13日 | 2025年7月3日 |
股息 | 2025年3月14日 | US$0.20Quarterly | 2025年3月14日 | 2025年4月4日 |
股息 | 2024年12月20日 | US$0.20Quarterly | 2024年12月20日 | 2025年1月3日 |
股息 | 2024年9月16日 | US$0.20Quarterly | 2024年9月16日 | 2024年10月4日 |
股息 | 2024年6月14日 | US$0.20Quarterly | 2024年6月14日 | 2024年7月5日 |
除息 2025年9月15日
US$0.20
Quarterly
2025年9月15日登记 · 支付日 2025年10月3日
除息 2025年6月13日
US$0.20
Quarterly
2025年6月13日登记 · 支付日 2025年7月3日
除息 2025年3月14日
US$0.20
Quarterly
2025年3月14日登记 · 支付日 2025年4月4日
除息 2024年12月20日
US$0.20
Quarterly
2024年12月20日登记 · 支付日 2025年1月3日
除息 2024年9月16日
US$0.20
Quarterly
2024年9月16日登记 · 支付日 2024年10月4日
除息 2024年6月14日
US$0.20
Quarterly
2024年6月14日登记 · 支付日 2024年7月5日
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4776.33万0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM3581万0.05%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap ETFVB3449.39万0.02%1853亿 USD0.03%US$288.16-0.46%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV2468.56万0.09%268.09亿 USD0.33%US$37.98+0.08%
Vanguard Morningstar Small-Cap Value ETFVBR2193.22万0.03%682亿 USD0.05%US$234.71+0.12%
Vanguard Extended Market ETFVXF1739.38万0.02%954亿 USD0.05%US$233.52-0.63%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1219.83万0.08%157.12亿 USD0.03%US$53.42-0.06%
Dimensional - US Targeted Value ETFDFAT1032.1万0.03%301.22亿 USD0.33%US$67.42+0.22%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMDimensional - US Targeted Value ETFDFATAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
